Conduit Pharmaceuticals Inc (CDT)

$1.74 +0.03 (1.75%)
Market Cap 5.41M
Revenue (ttm) 0.00
Net Income (ttm) -17.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 109,702
Avg Vol 422,744
Day's Range N/A - N/A
Shares Out 2.93M
Stochastic %K 5%
Beta 1.93
Analysts Strong Buy
Price Target N/A

Company Profile

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has stra...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 491 9132
Address:
4581 Tamiami Trail North, Suite 200, Naples, United States
VibraniumClaw
VibraniumClaw Jan. 14 at 1:57 AM
[@CoralSharkie playing chess while others playing checkers 😮‍❄️ [Different vision. Different execution. If you’re not paying attention, you’re behind. One follow = clarity. Real ones already know 💎 $RIME $NIVF $CDT $GSIW > on watch as well
0 · Reply
Sam201
Sam201 Jan. 14 at 1:03 AM
$CDT n more today!
0 · Reply
ParabolicWhisper
ParabolicWhisper Jan. 13 at 8:47 PM
$LPSN $LGCL $JYD $CDT Voo
0 · Reply
416Area
416Area Jan. 9 at 11:58 PM
$CDT This became trash since the new CEO was elected last April...Don't give him your money , he has nothing to offer.
0 · Reply
Love_To_Learn
Love_To_Learn Jan. 9 at 8:13 PM
$HRTX $CDT need to make a change to both of u
0 · Reply
TATTED_KEN
TATTED_KEN Jan. 8 at 6:04 PM
Currently holding $CDT $ARBK and added $KUST (fresh RS)
0 · Reply
max315
max315 Jan. 5 at 2:56 PM
$CDT up 25c on something that continues to lose. just fun to beat the algos. Nothing really to see here. Prob go back down unless a group gets a hold of it.
1 · Reply
TATTED_KEN
TATTED_KEN Jan. 5 at 2:34 PM
$ARBK $5.5 🎯 $CDT 🎯 $2+ waiting on $SPHL
0 · Reply
BullJack
BullJack Jan. 2 at 11:24 PM
$CDT They license shelved drugs from big pharma post stage I, run phase II and then offload the drugs post stage II. In a risky sector with so much randomness and uncertainty, investors are really supposed to expect this to be a sustainable business model? I don’t doubt that it’s a noble endeavour by the company, but the stock price speak for itself. A 100k investment a year ago would leave you with 100 bucks today.
0 · Reply
Bullish_Bearish88
Bullish_Bearish88 Dec. 31 at 5:49 PM
$CDT I mentioned this couple month ago this company is straight garbage. You want your money back wait for next R/S which will be in next couple weeks then short.
0 · Reply
Latest News on CDT
CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

Jan 2, 2026, 8:30 AM EST - 11 days ago

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

CDT Equity Increases Bitcoin Holding

Oct 17, 2025, 8:30 AM EDT - 3 months ago

CDT Equity Increases Bitcoin Holding

CDT Equity Inc. Announces Reverse Stock Split

Oct 9, 2025, 8:00 AM EDT - 3 months ago

CDT Equity Inc. Announces Reverse Stock Split

CDT Executes Cryptocurrency Treasury Reserve Strategy

Sep 17, 2025, 8:30 AM EDT - 4 months ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Aug 26, 2025, 8:30 AM EDT - 5 months ago

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Conduit to Change Name to CDT Equity Inc.

Aug 5, 2025, 8:30 AM EDT - 5 months ago

Conduit to Change Name to CDT Equity Inc.

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 8, 2025, 8:30 AM EDT - 6 months ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jul 7, 2025, 8:30 AM EDT - 6 months ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Jun 4, 2025, 8:30 AM EDT - 8 months ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 22, 2025, 8:30 AM EDT - 8 months ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 21, 2025, 8:30 AM EDT - 8 months ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 16, 2025, 8:30 AM EDT - 8 months ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 9, 2025, 8:30 AM EDT - 8 months ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

May 8, 2025, 8:30 AM EDT - 8 months ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Conduit Pharmaceuticals Announces Leadership Changes

Apr 16, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Announces Leadership Changes

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Apr 11, 2025, 8:30 AM EDT - 9 months ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 31, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 19, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Mar 6, 2025, 9:35 AM EST - 11 months ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 20, 2025, 8:00 AM EST - 11 months ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 13, 2025, 8:00 AM EST - 11 months ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 11, 2025, 9:00 AM EST - 1 year ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Feb 7, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Jan 28, 2025, 5:30 AM EST - 1 year ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Dec 12, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 21, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 19, 2024, 4:30 PM EST - 1 year ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 4, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Nov 1, 2024, 4:45 PM EDT - 1 year ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

Aug 8, 2024, 6:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

AstraZeneca furthers ambition to transform outcomes in early lung cancer and ​redefine metastatic breast cancer treatment at ASCO 2024​

May 22, 2024, 7:00 AM EDT - 1 year ago

AstraZeneca furthers ambition to transform outcomes in early lung cancer and ​redefine metastatic breast cancer treatment at ASCO 2024​

AZN

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

May 21, 2024, 8:00 AM EDT - 1 year ago

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Mar 19, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Mar 11, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Jan 31, 2024, 8:30 AM EST - 2 years ago

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 2 years ago

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

Sep 22, 2023, 9:01 AM EDT - 2 years ago

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

VibraniumClaw
VibraniumClaw Jan. 14 at 1:57 AM
[@CoralSharkie playing chess while others playing checkers 😮‍❄️ [Different vision. Different execution. If you’re not paying attention, you’re behind. One follow = clarity. Real ones already know 💎 $RIME $NIVF $CDT $GSIW > on watch as well
0 · Reply
Sam201
Sam201 Jan. 14 at 1:03 AM
$CDT n more today!
0 · Reply
ParabolicWhisper
ParabolicWhisper Jan. 13 at 8:47 PM
$LPSN $LGCL $JYD $CDT Voo
0 · Reply
416Area
416Area Jan. 9 at 11:58 PM
$CDT This became trash since the new CEO was elected last April...Don't give him your money , he has nothing to offer.
0 · Reply
Love_To_Learn
Love_To_Learn Jan. 9 at 8:13 PM
$HRTX $CDT need to make a change to both of u
0 · Reply
TATTED_KEN
TATTED_KEN Jan. 8 at 6:04 PM
Currently holding $CDT $ARBK and added $KUST (fresh RS)
0 · Reply
max315
max315 Jan. 5 at 2:56 PM
$CDT up 25c on something that continues to lose. just fun to beat the algos. Nothing really to see here. Prob go back down unless a group gets a hold of it.
1 · Reply
TATTED_KEN
TATTED_KEN Jan. 5 at 2:34 PM
$ARBK $5.5 🎯 $CDT 🎯 $2+ waiting on $SPHL
0 · Reply
BullJack
BullJack Jan. 2 at 11:24 PM
$CDT They license shelved drugs from big pharma post stage I, run phase II and then offload the drugs post stage II. In a risky sector with so much randomness and uncertainty, investors are really supposed to expect this to be a sustainable business model? I don’t doubt that it’s a noble endeavour by the company, but the stock price speak for itself. A 100k investment a year ago would leave you with 100 bucks today.
0 · Reply
Bullish_Bearish88
Bullish_Bearish88 Dec. 31 at 5:49 PM
$CDT I mentioned this couple month ago this company is straight garbage. You want your money back wait for next R/S which will be in next couple weeks then short.
0 · Reply
Nevilhch
Nevilhch Dec. 30 at 11:48 PM
$CDT I told them to short sell to recover, but everyone, including Chubby, said Chatgpt said otherwise, jajaja😂🤣😂🤣. They would have recovered something or gotten out by now. There are a lot of pumpers here; it's best not to trust them.
3 · Reply
Bears2354
Bears2354 Dec. 30 at 10:43 PM
$CMND got had just like $CDT got me earlier this year. These 2 are by far the worst investments I have made.
1 · Reply
Bears2354
Bears2354 Dec. 30 at 10:40 PM
$CDT so crazy to watch this go To nothing the last 2 years 😮 🤯
1 · Reply
Nevilhch
Nevilhch Dec. 30 at 8:56 PM
$CDT i'm here
0 · Reply
max315
max315 Dec. 30 at 8:47 PM
$CDT may yolo some from 1.2s with a stop under 1.19. Shocked a group has not found this.
0 · Reply
max315
max315 Dec. 30 at 8:29 PM
$CDT Where's the guy that's been claiming to short this from 4 to 1? You're almost there.
1 · Reply
Fringe
Fringe Dec. 30 at 8:28 PM
$CDT saw this in June. Pure trash company.
0 · Reply
TATTED_KEN
TATTED_KEN Dec. 29 at 5:26 PM
$CDT adding here $1.4s
0 · Reply
max315
max315 Dec. 29 at 3:01 PM
$CDT yes cashless warrants = bottomless. Prob under 1 and another r/s. Keep thinking one day a 'group' will find it but hasn't happened yet and not worth trying to "catch bottom"
0 · Reply
Sam201
Sam201 Dec. 27 at 2:16 PM
$CDT I did miss the option about cashless exercise. Meaning this can be bottomless once effective. Play accordingly.
1 · Reply
Sam201
Sam201 Dec. 26 at 7:49 PM
$CDT n accumulated some more!
0 · Reply
Nevilhch
Nevilhch Dec. 26 at 7:45 PM
$CDT I'm out of here, you know-it-alls who analyze everything with chatgpt... Sayonara baby 🤣😎🤑
0 · Reply